lctx: the balance sheet

MyFinsight

For the quarter ending 2025-09-30, LCTX has $89,639K in assets.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Balance Sheets	2025-09-30	2025-06-30
Total assets	89,639	90,799

Lineage's shareholders' equity	22,040	48,385
Noncontrolling deficit	-1,244	-1,273
Total shareholders equity	20,796	47,112
Total liabilities and shareholders equity	89,639	90,799

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30, LCTX has $89,639K in assets.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Balance Sheets	2025-09-30	2025-06-30
Total assets	89,639	90,799

Lineage's shareholders' equity	22,040	48,385
Noncontrolling deficit	-1,244	-1,273
Total shareholders equity	20,796	47,112
Total liabilities and shareholders equity	89,639	90,799

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Lineage Cell Therapeutics, Inc. (LCTX)